Life Science Instrumentation Market (By Technology: Spectroscopy, Chromatography, Flow Cytometry, Next Generation Sequencing, Polymerase Chain Reaction, Microscopy; By Application: Research and Clinical; By End User: Pharma-Biotech, Agri and Food Industry, Hospitals & Diagnostic Labs) - Global Industry Analysis, Size, Share, Growth, Trends, Regional Outlook, and Forecast 2023– 2032
The global life science instrumentation market was valued at US$ 61 billion in 2022 and is expected to reach over US$ 100.79 billion by 2032, poised to grow at a compound annual growth rate (CAGR) of 5.20% from 2023 to 2032.
Access our Healthcare Data Intelligence Tool with 10000+ Database, Visit: Towards Healthcare
The U.S. life science instrumentation market reached US$ 13.56 billion in 2022 and is priicted to be worth over US$ 22.19 billion by 2032, at a CAGR of 5.10% from 2023 to 2032.
Based on the region, the North America segment dominated the global life science instrumentation market in 2022, in terms of revenue and is estimated to sustain its dominance during the forecast period. The life science instrumentation is employed in a variety of applications in North America. The life science instrumentation has shown to be a useful tool for a variety of applications including pharmaceutical applications, final product testing, and food safety testing.
On the other hand, in the life science instrumentation market, the Asia-Pacific region is one of the most profitable regions. The region’s growth is being fueled by strategic expansions by important market players in rising Asian countries, the growing pharmaceutical industry in China and India.
The life science instruments are commonly utilized for analytical techniques and method validation during drug development. Nowadays, several innovative technologies are used in the medication development process. The life science instrumentation market will benefit from rising demand for analytical instruments, strong growth in the biotechnology and pharmaceutical industries, and expanding application area of analytical instruments. As sequencing technologies aids in determining the origin of an illness, increased attention on next generation sequencing (NGS) is expected to promote market growth.
The life science instrumentation market is expected to benefit from an increase in research and development activities in various sectors such as biotechnology, pharmaceuticals, food and beverage, and agriculture. Moreover, the increased number of novel product launches by numerous prominent players is expected to boost the growth of the life science instrumentation market during the forecast period.
The growing incidence of chronic diseases in both developing and developed countries is projected to increase the demand for effective technology for early disease diagnosis, which will drive up the demand for instruments in life science. Furthermore, the market for life science instrumentation is being driven by increased public-private investments in life science research and technical developments in analytical equipment. However, the high cost of life science instrumentation is inhibiting the market’s expansion.
During the forecast period, the life science instrumentation market is expected to rise due to rising demand for effective diagnostic technologies and increasing government funding in the development of new instruments utilized in the life sciences and medical devices sectors. The growing applications of life science instruments in other industries, such as the food and beverage industry is expected to boost the life science instrumentation market growth during the forecast period.
The majority of life science and analytical technologies are utilized to study DNA in order to develop new pharmaceutical medications and determine food quality. The companies are heavily investing in this area in order to increase the market growth. The development of new products will improve the ability to accurately diagnose samples. It will assist in the targeting of treatment for a specific patient.
The growth of life science instrumentation market is projected to be hampered by high maintenance and operation costs. In addition, without an alternative, diagnosing the samples will be difficult because the lack of such intricate equipment would make the process much more complicated and cause the outcome to be delayed.
| Market Size in 2023 | US$ 63.87 Billion |
| Growth Rate From 2023 to 2032 | CAGR of 5.20% |
| Revenue Projection by 2032 | US$ 100.79 Billion |
| Largest Market | North America |
| Fastest Growing Market | Asia Pacific |
| Base Year | 2022 |
| Forecast Period | 2023 to 2032 |
| Segments Covered |
|
| Companies Mentioned | Bruker Corporation, Eppendorf AG, Hitachi High Technologies Corporation, Becton Dickinson and Company, Bio-Rad Laboratories Inc., Waters Corporation, Thermo Fisher Scientific, Agilent Technologies, Shimadzu Corporation, Qiagen N.V. |
Based on the technology, the next generation sequencing (NGS) segment dominates the life science instrumentation market during the forecast period. The next generation sequencing (NGS) segment is predicted to increase at the fastest CAGR throughout the forecast period, owing to the benefits of NGS technologies in DNA sequencing, which give much higher productivity and reduce the requirement for fragment-cloning processes. Moreover, the constant technological developments and the rising availability of less expensive sequencing platforms are likely to fuel the expansion of the life science instrumentation market.
The microscopy is expected to grow at rapid pace during the forecast period. The expanding healthcare sector, combined with rising applications from emerging economies, would further boost numerous prospects that will contribute to the development of the microscopy segment.
Based on the application, the research dominates the life science instrumentation market during the forecast period. The expanding number of research studies along with increased public-private funding in the field of genomic researches, as well as the continued trend of laboratory automation and robotics, all contributes to the substantial share of the research applications segment.
The clinical segment is expected to grow at rapid pace during the forecast period. The rising frequency of chronic disease, as well as the expanding demand for clinical trials in emerging countries, is driving the growth of segment.
Based on the end user, the pharma-biotech dominate the life science instrumentation market during the forecast period. The life science instruments are used widely in pharmaceutical and biotechnology industries. Pharmaceutical instrumentation necessitates the highest levels of precision, dependability, and quality.
The hospitals & diagnostic labs is expected to grow at rapid pace during the forecast period. The utilization of life science instrumentation in diagnostic labs and hospitals is on a large scale, owing to rising prevalence of chronic diseases and rising R&D investments.
Key Companies & Market Share Insights
The market growth strategies such as acquisitions, mergers, and collaborations are being used by key market players in the life science instrumentation market to expand their product portfolios. Only a few firms have come up with innovative technologies and new product launches.
Tecan Trading AG introduced NGS DreamPre in February 2019, a fully automated approach to next generation sequencing (NGS) that produces quality-controlled, sequencing-ready NGS libraries in a matter of hours with no operator interaction and no sample loss.
Segments Covered in the Report
By Technology
By Application
By End User
By Geography
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. COVID 19 Impact on Life Science Instrumentation Market
5.1. COVID-19 Landscape: Life Science Instrumentation Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
Chapter 6. Market Dynamics Analysis and Trends
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
Chapter 7. Competitive Landscape
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
Chapter 8. Global Life Science Instrumentation Market, By Technology
8.1. Life Science Instrumentation Market, by Technology Type, 2023-2032
8.1.1. Spectroscopy
8.1.1.1. Market Revenue and Forecast (2020-2032)
8.1.2. Chromatography
8.1.2.1. Market Revenue and Forecast (2020-2032)
8.1.3. Flow Cytometry
8.1.3.1. Market Revenue and Forecast (2020-2032)
8.1.4. Next Generation Sequencing (NGS)
8.1.4.1. Market Revenue and Forecast (2020-2032)
8.1.5. Polymerase Chain Reaction (PCR)
8.1.5.1. Market Revenue and Forecast (2020-2032)
8.1.6. Microscopy
8.1.6.1. Market Revenue and Forecast (2020-2032)
8.1.7. Liquid Handling
8.1.7.1. Market Revenue and Forecast (2020-2032)
8.1.8. Electrophoresis
8.1.8.1. Market Revenue and Forecast (2020-2032)
8.1.9. Cell Counting
8.1.9.1. Market Revenue and Forecast (2020-2032)
8.1.10. Others
8.1.10.1. Market Revenue and Forecast (2020-2032)
Chapter 9. Global Life Science Instrumentation Market, By Application
9.1. Life Science Instrumentation Market, by Application, 2023-2032
9.1.1. Research
9.1.1.1. Market Revenue and Forecast (2020-2032)
9.1.2. Clinical
9.1.2.1. Market Revenue and Forecast (2020-2032)
Chapter 10. Global Life Science Instrumentation Market, By End User
10.1. Life Science Instrumentation Market, by End User, 2023-2032
10.1.1. Pharma-Biotech
10.1.1.1. Market Revenue and Forecast (2020-2032)
10.1.2. Agri and Food Industry
10.1.2.1. Market Revenue and Forecast (2020-2032)
10.1.3. Hospitals & Diagnostic Labs
10.1.3.1. Market Revenue and Forecast (2020-2032)
Chapter 11. Global Life Science Instrumentation Market, Regional Estimates and Trend Forecast
11.1. North America
11.1.1. Market Revenue and Forecast, by Technology (2020-2032)
11.1.2. Market Revenue and Forecast, by Application (2020-2032)
11.1.3. Market Revenue and Forecast, by End User (2020-2032)
11.1.4. U.S.
11.1.4.1. Market Revenue and Forecast, by Technology (2020-2032)
11.1.4.2. Market Revenue and Forecast, by Application (2020-2032)
11.1.4.3. Market Revenue and Forecast, by End User (2020-2032)
11.1.5. Rest of North America
11.1.5.1. Market Revenue and Forecast, by Technology (2020-2032)
11.1.5.2. Market Revenue and Forecast, by Application (2020-2032)
11.1.5.3. Market Revenue and Forecast, by End User (2020-2032)
11.2. Europe
11.2.1. Market Revenue and Forecast, by Technology (2020-2032)
11.2.2. Market Revenue and Forecast, by Application (2020-2032)
11.2.3. Market Revenue and Forecast, by End User (2020-2032)
11.2.4. UK
11.2.4.1. Market Revenue and Forecast, by Technology (2020-2032)
11.2.4.2. Market Revenue and Forecast, by Application (2020-2032)
11.2.4.3. Market Revenue and Forecast, by End User (2020-2032)
11.2.5. Germany
11.2.5.1. Market Revenue and Forecast, by Technology (2020-2032)
11.2.5.2. Market Revenue and Forecast, by Application (2020-2032)
11.2.5.3. Market Revenue and Forecast, by End User (2020-2032)
11.2.6. France
11.2.6.1. Market Revenue and Forecast, by Technology (2020-2032)
11.2.6.2. Market Revenue and Forecast, by Application (2020-2032)
11.2.6.3. Market Revenue and Forecast, by End User (2020-2032)
11.2.7. Rest of Europe
11.2.7.1. Market Revenue and Forecast, by Technology (2020-2032)
11.2.7.2. Market Revenue and Forecast, by Application (2020-2032)
11.2.7.3. Market Revenue and Forecast, by End User (2020-2032)
11.3. APAC
11.3.1. Market Revenue and Forecast, by Technology (2020-2032)
11.3.2. Market Revenue and Forecast, by Application (2020-2032)
11.3.3. Market Revenue and Forecast, by End User (2020-2032)
11.3.4. India
11.3.4.1. Market Revenue and Forecast, by Technology (2020-2032)
11.3.4.2. Market Revenue and Forecast, by Application (2020-2032)
11.3.4.3. Market Revenue and Forecast, by End User (2020-2032)
11.3.5. China
11.3.5.1. Market Revenue and Forecast, by Technology (2020-2032)
11.3.5.2. Market Revenue and Forecast, by Application (2020-2032)
11.3.5.3. Market Revenue and Forecast, by End User (2020-2032)
11.3.6. Japan
11.3.6.1. Market Revenue and Forecast, by Technology (2020-2032)
11.3.6.2. Market Revenue and Forecast, by Application (2020-2032)
11.3.6.3. Market Revenue and Forecast, by End User (2020-2032)
11.3.7. Rest of APAC
11.3.7.1. Market Revenue and Forecast, by Technology (2020-2032)
11.3.7.2. Market Revenue and Forecast, by Application (2020-2032)
11.3.7.3. Market Revenue and Forecast, by End User (2020-2032)
11.4. MEA
11.4.1. Market Revenue and Forecast, by Technology (2020-2032)
11.4.2. Market Revenue and Forecast, by Application (2020-2032)
11.4.3. Market Revenue and Forecast, by End User (2020-2032)
11.4.4. GCC
11.4.4.1. Market Revenue and Forecast, by Technology (2020-2032)
11.4.4.2. Market Revenue and Forecast, by Application (2020-2032)
11.4.4.3. Market Revenue and Forecast, by End User (2020-2032)
11.4.5. North Africa
11.4.5.1. Market Revenue and Forecast, by Technology (2020-2032)
11.4.5.2. Market Revenue and Forecast, by Application (2020-2032)
11.4.5.3. Market Revenue and Forecast, by End User (2020-2032)
11.4.6. South Africa
11.4.6.1. Market Revenue and Forecast, by Technology (2020-2032)
11.4.6.2. Market Revenue and Forecast, by Application (2020-2032)
11.4.6.3. Market Revenue and Forecast, by End User (2020-2032)
11.4.7. Rest of MEA
11.4.7.1. Market Revenue and Forecast, by Technology (2020-2032)
11.4.7.2. Market Revenue and Forecast, by Application (2020-2032)
11.4.7.3. Market Revenue and Forecast, by End User (2020-2032)
11.5. Latin America
11.5.1. Market Revenue and Forecast, by Technology (2020-2032)
11.5.2. Market Revenue and Forecast, by Application (2020-2032)
11.5.3. Market Revenue and Forecast, by End User (2020-2032)
11.5.4. Brazil
11.5.4.1. Market Revenue and Forecast, by Technology (2020-2032)
11.5.4.2. Market Revenue and Forecast, by Application (2020-2032)
11.5.4.3. Market Revenue and Forecast, by End User (2020-2032)
11.5.5. Rest of LATAM
11.5.5.1. Market Revenue and Forecast, by Technology (2020-2032)
11.5.5.2. Market Revenue and Forecast, by Application (2020-2032)
11.5.5.3. Market Revenue and Forecast, by End User (2020-2032)
Chapter 12. Company Profiles
12.1. Bruker Corporation
12.1.1. Company Overview
12.1.2. Product Offerings
12.1.3. Financial Performance
12.1.4. Recent Initiatives
12.2. Eppendorf AG
12.2.1. Company Overview
12.2.2. Product Offerings
12.2.3. Financial Performance
12.2.4. Recent Initiatives
12.3. Hitachi High Technologies Corporation
12.3.1. Company Overview
12.3.2. Product Offerings
12.3.3. Financial Performance
12.3.4. Recent Initiatives
12.4. Becton Dickinson and Company
12.4.1. Company Overview
12.4.2. Product Offerings
12.4.3. Financial Performance
12.4.4. Recent Initiatives
12.5. Bio-Rad Laboratories Inc.
12.5.1. Company Overview
12.5.2. Product Offerings
12.5.3. Financial Performance
12.5.4. Recent Initiatives
12.6. Waters Corporation
12.6.1. Company Overview
12.6.2. Product Offerings
12.6.3. Financial Performance
12.6.4. Recent Initiatives
12.7. Thermo Fisher Scientific
12.7.1. Company Overview
12.7.2. Product Offerings
12.7.3. Financial Performance
12.7.4. Recent Initiatives
12.8. Agilent Technologies
12.8.1. Company Overview
12.8.2. Product Offerings
12.8.3. Financial Performance
12.8.4. Recent Initiatives
12.9. Shimadzu Corporation
12.9.1. Company Overview
12.9.2. Product Offerings
12.9.3. Financial Performance
12.9.4. Recent Initiatives
12.10. Qiagen N.V.
12.10.1. Company Overview
12.10.2. Product Offerings
12.10.3. Financial Performance
12.10.4. Recent Initiatives
Chapter 13. Research Methodology
13.1. Primary Research
13.2. Secondary Research
13.3. Assumptions
Chapter 14. Appendix
14.1. About Us
14.2. Glossary of Terms
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client
Get a Sample